Showing results (2721-2730 of 8,098) with videos related to
Sort By:
Pageof 810
Current Medicinal Chemistry|May 17, 2011
Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesisL A Braga-Silva, A L S SantosCurrent Medicinal Chemistry|March 25, 2011
Recent advances in studies on hydroxamates as matrix metalloproteinase inhibitors: a reviewR K Yadav, S P Gupta, P K Sharma, et al.Current Medicinal Chemistry|March 25, 2011
Developing histone deacetylase inhibitors as anti-cancer therapeuticsB Venugopal, T R J EvansCurrent Medicinal Chemistry|March 25, 2011
Targeted therapies and other agents as first-line maintenance and beyond: particular benefit in pulmonary adenocarcinoma patientsF Petrelli, K Borgonovo, M Cabiddu, et al.Current Medicinal Chemistry|April 7, 2011
Targeting FK506 binding proteins to fight malarial and bacterial infections: current advances and future perspectivesN Bharatham, M W Chang, H S YoonCurrent Medicinal Chemistry|April 7, 2011
Claudin as a target for drug developmentA Takahashi, M Kondoh, H Suzuki, et al.Current Medicinal Chemistry|April 7, 2011
Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatmentL De Santi, G Polimeni, S Cuzzocrea, et al.Current Medicinal Chemistry|April 7, 2011
Drugs of abuse: epigenetic mechanisms in toxicity and addictionL Kovatsi, D Fragou, V Samanidou, et al.Current Medicinal Chemistry|April 27, 2011
Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseasesV M Costa, F Carvalho, M L Bastos, et al.Pageof 810